Erydel Spa has a total of 38 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Italy and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ZOGENIX INC, NEURALIGHT HD LLC and JAGO RES AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Italy | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 3 | |
#5 | Brazil | 3 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Israel | 2 | |
#9 | Republic of Korea | 2 | |
#10 | Mexico | 2 | |
#11 | Singapore | 2 | |
#12 | United States | 2 | |
#13 | Costa Rica | 1 | |
#14 | Morocco | 1 | |
#15 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Medical technology | |
#5 | Machines |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Enzymes | |
#5 | Syringes | |
#6 | Measuring microorganism processes | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Mambrini Giovanni | 24 |
#2 | Capogrossi Giovanni | 13 |
#3 | Benatti Luca | 13 |
#4 | Mandolini Marco | 13 |
#5 | Serafini Sonja | 11 |
#6 | Magnani Mauro | 8 |
#7 | Biagiotti Sara | 7 |
#8 | Menotta Michele | 6 |
#9 | Giovanni Mambrini | 4 |
#10 | Marco Mandolini | 3 |
Publication | Filing date | Title |
---|---|---|
EP3247805A1 | Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment | |
KR20160005781A | Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes | |
WO2011135431A1 | Method for introducing at least one compound within erythrocytes for therapeutical and/or diagnostic use | |
KR20130118728A | Apparatus and kit for encapsulating at least one compound for therapeutic and/or diagnostic use in erythrocytes | |
EP2437736A2 | Drug delivery systems | |
EP2043697A2 | Erythrocytes containing contrasting agents for magnetic resonance imaging |